These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 17017830

  • 1. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ.
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J, Goa KL.
    CNS Drugs; 2003 Sep; 17(5):343-62. PubMed ID: 12665392
    [Abstract] [Full Text] [Related]

  • 4. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P, Lönn SL, Overø KF.
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [Abstract] [Full Text] [Related]

  • 5. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM, Llorca PM, Despiegel N, Verpillat P.
    Encephale; 2004 Feb; 30(2):158-66. PubMed ID: 15107719
    [Abstract] [Full Text] [Related]

  • 6. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC.
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [Abstract] [Full Text] [Related]

  • 7. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
    Montgomery SA, Nil R, Dürr-Pal N, Loft H, Boulenger JP.
    J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
    [Abstract] [Full Text] [Related]

  • 8. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.
    J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
    [Abstract] [Full Text] [Related]

  • 9. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW, Brown BL, Shwalb DA, Godfrey K, Larcher AM.
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [Abstract] [Full Text] [Related]

  • 10. A direct comparison of effect sizes from the clinical global impression-improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder.
    Hedges DW, Brown BL, Shwalb DA.
    Hum Psychopharmacol; 2009 Jan; 24(1):35-40. PubMed ID: 18980264
    [Abstract] [Full Text] [Related]

  • 11. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [Abstract] [Full Text] [Related]

  • 12. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G, Beeské S, Stahl SM.
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
    Davidson JR, Bose A, Wang Q.
    J Clin Psychiatry; 2005 Nov; 66(11):1441-6. PubMed ID: 16420082
    [Abstract] [Full Text] [Related]

  • 14. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
    Kroenke K, Messina N, Benattia I, Graepel J, Musgnung J.
    J Clin Psychiatry; 2006 Jan; 67(1):72-80. PubMed ID: 16426091
    [Abstract] [Full Text] [Related]

  • 15. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A.
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [Abstract] [Full Text] [Related]

  • 16. Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder.
    Lecrubier Y, Dolberg OT, Andersen HF, Weiller E.
    Eur Arch Psychiatry Clin Neurosci; 2008 Apr; 258(3):171-8. PubMed ID: 18084791
    [Abstract] [Full Text] [Related]

  • 17. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
    Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C.
    Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
    [Abstract] [Full Text] [Related]

  • 18. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ, Gergel I, Bose A.
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [Abstract] [Full Text] [Related]

  • 19. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM, Gergel I, Li D.
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [Abstract] [Full Text] [Related]

  • 20. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.
    Depress Anxiety; 2008 Nov; 25(1):46-54. PubMed ID: 17149753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.